4th Quarter - Report

PFIZER INC. for PFIZER INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$5,590,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 20, 2010 $5,590,000 Replaced
4th Quarter - Report Jan 26, 2010 $5,590,000 Replaced
4th Quarter - Amendment Sep 21, 2010 $6,200,000 Yes

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

Wyeth Acquisition

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —
ANGELA WALKER RIEMER New —

Contacted: Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Treasury, Dept of; Food & Drug Administration (FDA); State, Dept of (DOS); SENATE; Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia market access (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Finland Patent Issues Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
STEPHANIE HENNING —
ANTHONY PRINCIPI —

Contacted: Treasury, Dept of; Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); State, Dept of (DOS); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); SENATE; Office of Management & Budget (OMB); Defense, Dept of (DOD); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Agriculture AGR

H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
ANTHONY PRINCIPI —

Contacted: SENATE; State, Dept of (DOS); Treasury, Dept of; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA); Defense, Dept of (DOD); Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2400 (111th), H.R. 1549 (111th)

Taxation/Internal Revenue Code TAX

H.R. 198 - Healthcare Tax Deduction Act of 2009 H.R. 422 - R&E tax credit extension and Enhancement H.R. 2098 - CFC Look Through Extension S. 1203 - R& E tax credit extension and Enhancement Deferral Deferral for active-financing income- extension Tax Treaties - France, New Zealand, Malta

LobbyistCovered position, as disclosed
KIMBERLY JANE PINTER —
ANTHONY PRINCIPI —

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Executive Office of the President (EOP); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS)

Bills named: H.R. 198 (111th), H.R. 422 (111th), S. 1203 (111th), H.R. 2098 (111th)

Consumer Issues/Safety/Products CSP

S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —
ANGELA WALKER RIEMER New —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); State, Dept of (DOS); Treasury, Dept of; Defense, Dept of (DOD); Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA)

Bills named: H.R. 1256 (111th), H.R. 91 (111th), S. 767 (111th), S. 1383 (111th), H.R. 573 (111th), S. 80 (111th), H.R. 759 (111th), S. 501 (111th), H.R. 163 (111th), H.R. 1427 (111th), S. 882 (111th), H.R. 1548 (111th), H.R. 1259 (111th)

Copyright/Patent/Trademark CPT

S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
JOHN PAUL HALLIWELL —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Treasury, Dept of; State, Dept of (DOS); Defense, Dept of (DOD); Patent & Trademark Office (PTO); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 610 (111th), H.R. 1706 (111th), S. 369 (111th), S. 515 (111th), H.R. 1260 (111th), H.R. 1548 (111th), S. 299 (111th)

Budget/Appropriations BUD

Administration budget proposal, deferral and other international tax issues H.R.3293 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
BRONWEN KAYE New —
KIMBERLY JANE PINTER —
ANTHONY PRINCIPI —

Contacted: Food & Drug Administration (FDA); Office of Management & Budget (OMB); Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Executive Office of the President (EOP); SENATE; State, Dept of (DOS)

Bills named: H.R. 3293 (111th)

Defense DEF

H.R. 1256 - Family Smoking and Prevention and Tobacco Control Act VA Drug Coverage Smoking Cessation Coverage

LobbyistCovered position, as disclosed
LOUIS A LAMARCA —

Contacted: Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Office of Management & Budget (OMB); SENATE; Treasury, Dept of; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); State, Dept of (DOS)

Bills named: H.R. 1256 (111th)

Health Issues HCR

Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D

LobbyistCovered position, as disclosed
MELISSA BISHOP-MURPHY —
CHRISTOPHER CAREY —
MARIA CINO Assistant Secretary & Director General of USFCS
JOHN PAUL HALLIWELL —
BRONWEN KAYE New —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —
ANGELA WALKER RIEMER New —

Contacted: Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Treasury, Dept of; SENATE; Patent & Trademark Office (PTO); State, Dept of (DOS); Food & Drug Administration (FDA); Defense, Dept of (DOD); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 301 (111th), H.R. 2 (111th), S.Con.Res. 13 (111th), H.R. 1548 (111th), H.R. 3590 (111th), H.R. 2366 (111th), H.R. 3200 (111th), H.R. 1549 (111th), S. 4 (111th), H.Con.Res. 85 (111th), H.R. 3962 (111th), H.R. 2400 (111th), S. 726 (111th), H.R. 1427 (111th), H.R. 1 (111th), S. 45 (111th), S. 717 (111th), S. 501 (111th), H.R. 15 (111th), H.R. 193 (111th)

Medicare/Medicaid MMM

H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 S. 1630 - Affordable Access to Prescription Medicine Act of 2009 S. 1679 - Affordable Heath Choices Act of 2009 Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
JOHN PAUL HALLIWELL —
ANTHONY PRINCIPI —

Contacted: Food & Drug Administration (FDA); State, Dept of (DOS); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Defense, Dept of (DOD); SENATE; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Commerce, Dept of (DOC)

Bills named: H.R. 3200 (111th), H.R. 574 (111th), S. 75 (111th), S. 1630 (111th), S. 1679 (111th), H.R. 2502 (111th), H.R. 684 (111th), H.R. 3675 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.